Stay informed about current Academy activities and news by clicking on the links below.
Webinar on December 7: Employer Best Practices and Tips for Using the Job and Fellowship Board
Read The Full Article
Limbrel Capsules by Primus Pharmaceuticals: FDA Advisory - Linked to Potentially Life-Threatening Health Problems
Greenstone Issues Voluntary Nationwide Recall of Diphenoxylate Hydrochloride and Atropine Sulfate Tablets, USP Due to Possible Sub Potent and Super Potent Tablets
AAPM&R Delegates Successfully Advocate for New Policy at AMA House of Delegates Meeting
15 Days Left to Submit an Informal Review Request - Review Your 2016 PQRS Feedback Report and 2016 Annual Quality and Resource Use Report Now
Update on Therapy Caps Legislation
Congratulations to Our 25-Year Members
Academy Endorses AMA Opioid Task Force Naloxone One-Pager
Compounded Glutamine, Arginine, and Carnitine Product for Injection by United Pharmacy: Compounding Risk Alert - FDA Investigates Two Adverse Events
Registry Participant Spotlight: Texas Pain Treatment Center
2017 AAPM&R Annual Business Meeting
Congratulations to the 2017 PM&R Journal Best Paper Award Recipients
CMS Finalizes Policies that Reduce Provider Burden, Lower Drug Prices
Experts Needed for Instructional Videos
Fresenius Kabi Issues Voluntary Nationwide Recall of Midazolam Injection, USP, 2 mg/2 mL Due to Reports of Blister Packages Containing Syringes of Ondansetron Injection, USP, 4 mg/2 mL